Palliative radiotherapy and the treatment of advanced or incurable cancer

  • J. Maisin
  • H. Maisin
  • C. Deckers
Part of the Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology book series (HDBRADIOL)


The term “palliative radiotherapy” is used here without restriction as to the method’s curative potential. Palliative radiotherapy as the writers understand it is radiotherapy applied to tumours in an advanced or very advanced state and which are beyond the usual or normal “stage of curability”. Its aim is to bring about temporary arrest of tumour growth, reduction in volume and temporary or even permanent disappearance, provided that the local and general condition of the patient make attainment of these objectives possible.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baclesse, F.: Roentgentherapy of carcinoma of the larynx. J. Fac. Radiol. (Lond.) 3, 3–12 (1951).CrossRefGoogle Scholar
  2. Baclesse, F.: Développement récent du traitement des cancers par les radiations. Acta Un. int. Cancr. 16, 1261–1268 (1960).PubMedGoogle Scholar
  3. Baclesse, F., et P.F. Denoix: Présentation du projet de classification clinique des tumeurs malignes du sein mise au point par l’Union Internationale contre le Cancer. J. Radiol. Électrol. 37, 173–175 (1956).Google Scholar
  4. Bacq, Z.M., and P. Alexander: Fundamentals of radiobiology. London: Butterworths Sci. Publ. 1954.Google Scholar
  5. Bacq, Z.M., A. Hervé, J. Lecomte, P. Fischer, J. Blavier, G. Dechamps, H. Le Bihan et P. Rayet: Protection contre le rayonnement X par la β-mercaptoéthylamine. Arch. int. Physiol. 59, 442–447 (1951).PubMedCrossRefGoogle Scholar
  6. Barnes, D.W.H., and J.F. Loutit: Treatment of murine leukemia with X-rays and homologous bone marrow. Brit. J. Haemat. 3, 241–252 (1957).PubMedCrossRefGoogle Scholar
  7. Becker, H.: Communication personnelle.Google Scholar
  8. Bekkum, D.W. van, and O. Vos: Immunological aspects of homo-and heterologous bone marrow transplantations in irradiated animals. J. cell. comp. Physiol. 50, 139–156 (1957).CrossRefGoogle Scholar
  9. Bergel, F., J.A. Stock, and Roy Wade: Peptides and macromolecules as carriers of cytotonic groups. Unesco Symposium on Cell Biology and Growth Inhibition. Academic Press 1960.Google Scholar
  10. Binkley, J.S.: National Cancer Conference in Memphis. Science News Letter 151, 55–70 (1949).Google Scholar
  11. Binkley, J.S.: Chemotherapy adjuvant to cancer surgery. A decade of personal experience 1948–1958. Acta Un. int. Cancr. 16, 822–827 (1960).Google Scholar
  12. Blokhin, N.: Our experience in chemotherapy of malignant tumours. Acta Un. int. Cancr. 16, 508–510 (1960).Google Scholar
  13. Boyland, E.: Aetiology of cancer of the bladder. Acta Un. int. Cancr. 16, 273–276 (1960).PubMedGoogle Scholar
  14. Burdette, W.J.: Etiology and treatment of leukemia. St. Louis: C.V. Mosby Co. 1958.Google Scholar
  15. Chevallier, A., et C. Burg: Utilisation du radio-phosphate de chrome colloïdal dans le traitement des tumeurs malignes. Conférence internat. sur l’utilisation de l’Energie Atomique à des Fins Pacifiques. Nations Unies Genève, 1956.Google Scholar
  16. Cochran, D.G., S. Holtz, and W.E. Powers: Rapid palliative treatment of breast carcinoma: preliminary report. Year Book of Cancer 1959-1960, p. 388-391. Chicago: Year Book Publ.Google Scholar
  17. Conard, R.A.: Some effects of ionizing radiation on the pysiology of the gastrointestinal tract. A review. Radiat. Res. 5, 167–188 (1956).CrossRefGoogle Scholar
  18. Conard, R.A., E.P. Cronkite, G. Brecher, and C.P.A. Strome: Experimental therapy of the gastrointestinal syndrome produced by lethal doses of ionizing radiation. J. appl. Physiol. 9, 227–233 (1966).Google Scholar
  19. Congdon, C.C., and I. Urso: Homologous bone marrow in the treatment of radiation injury in mice. Amer. J. Path. 33, 749–763 (1957).PubMedGoogle Scholar
  20. Congdon, C.C., and I. Urso: Isologous versus homologous bone marrow in the treatment of irradiated mice. Radiat. Res. 5, 474 (1956).Google Scholar
  21. Cordonnier, J.J., and W.B. Seaman: Betatron therapy in advanced carcinoma of urinary bladder. J. Urol. (Baltimore) 76, 256–262 (1956).Google Scholar
  22. Courard, H.: Note préliminaire sur la radiographie du larynx normal et du larynx cancéreux. J. belge Radiol. 13, 287 (1924).Google Scholar
  23. Courard, H.: Results and methods of treatment of cancer by radiation. Ann. Surg. 106, 584–598 (1937).CrossRefGoogle Scholar
  24. Crafoord, C.: Treatment of cancer of the lung. Acta Un. int. Cancr. 15, 443–446 (1959).PubMedGoogle Scholar
  25. Creech, O.J., E.T. Krementz, R.F. Ryan, K. Reemtsma, J.L. Elliot, and J.N. Winblad: Perfusion treatment of patients with cancer. J. Amer. med. Ass. 171, 2069–2075 (1959).CrossRefGoogle Scholar
  26. Creech, O.J., E.T. Krementz, R.F. Ryan, K. Reemtsma, J.L. Elliot, and J.N. Winblad: Experiences with isolation-perfusion technics in treatment of cancer. Year Book of Cancer 1959-1960, p. 362-364. Chicago: Year Book Publ.Google Scholar
  27. Cronkite, E.P., G. Brecher, and R.M. Wilbur: Development and use of a canine blood donor colony for experimental purposes; leukocyte and pla... transfusions in irradiation aplasia of the dog bone marrow. Milit. Surg. 114, 359–365 (1954).Google Scholar
  28. Cuccia, C.A., S. Jones, and C.M. Crigher: Clinical impressions in 100 consecutive cases of carcinoma of the urinary bladder treated by supervoltage. J. Urol. (Baltimore) 79, 99–109 (1958).Google Scholar
  29. Dargent, M., et M. Mayer: Valeur comparée de la surrénalectomie bilatérale et de la transplantation surréno-splénique dans le traitement du cancer du sein en phase avancée. Acta Un. int. Cancr. 15, 1071–1088 (1959).PubMedGoogle Scholar
  30. Deckers, C., et J. Maisin: Le cancer de la langue. J. Radiol. Électrol. 42, 655–662 (1961).PubMedGoogle Scholar
  31. Doherty, D.G., and W.T. Burnett jr.: The protective effect of Sβ — aminoethylisothiuronium · Br · HBr and related compounds against X-radiation death in mice. Proc. Soc. exp. Biol. (N.Y.) 89, 312–314 (1955).CrossRefGoogle Scholar
  32. Elson, L.A., D.A.G. Galton, and M. Till: The action of chlorambucil (C.B. 1348) and busulphan (myleran) on the haemopoietic organs of the rat. Brit. J. Haemat. 4, 355–374 (1958).PubMedCrossRefGoogle Scholar
  33. Ennuyer, A., G. Gricouroff, J. Ridremont et M. de Jaco: A propos de 70 tumeurs du testicule traitées à la Fondation Curie de 1922 à 1952. J. Radiol. Électrol. 40, 358–360 (1959).Google Scholar
  34. Evans, R.W.: Histological appearances of tumors. Edinburgh and London: E. & S. Livingstone 1956.Google Scholar
  35. Fessas, P., M.M. Wintrobe, R.B. Thompson, and G.E. Cartwright: Treatment of acute leukemia with cortisone and corticotropin. Arch. intern. Med. 94, 383–401 (1954).CrossRefGoogle Scholar
  36. Friedell, H.L.C., I. Thomas, and J.S. Krohmer: Description of a Sr90 beta-ray applicator and its use on the eye. Amer. J. Roentgenol. 65, 232–244 (1951).Google Scholar
  37. Gibbel, M., J. Cross, and I. Ariel: Cancer of the tongue: review of 330 cases. Cancer (Philad.) 2, 411–420 (1949).CrossRefGoogle Scholar
  38. Gibson, J.H., F.F. Allbritten, J.Y. Templeton, and Th. F. Nealon: Cancer of the lung — an analysis of 532 consecutive cases. Ann. Surg. 138, 489–501 (1953).CrossRefGoogle Scholar
  39. Graham, J.B., and R.M. Graham: The modification of resistance to ionizing radiation by humoral agents. Cancer (Philad.) 3, 709–717 (1950).CrossRefGoogle Scholar
  40. Gray, L.H.: Cellular radiobiology. Radiat. Res., Suppl. 1, 73–101 (1959).CrossRefGoogle Scholar
  41. Green, H.N.: Immunological aspects of cancer. Cancer, vol. 3 (Raven). London: Butterworth and Co. 1958.Google Scholar
  42. Gross, S.W., and A.P. Friedman: Cerebral metastases from a mixed tumor of the parotid gland. Neurology (Minneap.) 5, 435–437 (1955).CrossRefGoogle Scholar
  43. Hand, J.R., and A.C. Broders: Carcinoma of kidney: degree of malignancy in relation to factors bearing on prognosis. J. Urol. (Baltimore) 28, 199–216 (1932).Google Scholar
  44. Henschke, U.K.: Radioisotopes for implantation. Proc. Intern. Conf. on Peaceful Uses of Atomic Energy. United Nationals, New York 1956.Google Scholar
  45. Jackson, K.J., R. Rhodes, and C. Entenman: Electrolyte excretion in the rat after severe intestinal damage by X-irradiation. Radiat. Res. 8, 361–373 (1958).PubMedCrossRefGoogle Scholar
  46. Jacobsson, F.: Carcinoma of the tongue: a clinical study of 277 cases treated at Radiumhemmet (1931-1942). Acta radiol. (Stockh.) 68, 1–184 (1948).Google Scholar
  47. Krementz, E.T., O. Creech, R.F. Ryan, and J.N. Winblad: Treatment of cancer by regional perfusion with chemotherapeutic agents through and extra corporeal circuit. Acta Un. int. Cancr. 16, 874–886 (1960).PubMedGoogle Scholar
  48. Langendorff, H., H.J. Melching, and H.A. Ladner: 5-Hydroxytryptamine as a radiation protective substance in animals. Int. J. Radiat. Biol. 1, 24–27 (1959).CrossRefGoogle Scholar
  49. Larionov, L.F.: Chemotherapy of malignant tumors. Year Book of Cancer 1959-1960. Chicago: Year Book Publ.Google Scholar
  50. Larionov, L.F.: An approach to the creation of antitumour drugs with diverse action spectra. Unesco Symposium on Cell Biology and Growth Inhibition. London: Academic Press 1960.Google Scholar
  51. Lawrence, J.H., R.L. Dobson, B.V.A. Lowbeer, and B.R. Brown: Chronic myelogenous leukemia: a study of 129 cases in which treatment was with radioactive phosphorus. J. Amer. med. Ass. 126, 672–677 (1948).CrossRefGoogle Scholar
  52. Ledlie, R.: British practice in radiotherapy. London: Butterworths & Co. 1955.Google Scholar
  53. Leroux-Robert, J., A. Ennuyer, and R. Calle: Treatment of cancer and allied diseases (G.T. Pack and T.M. Ariel), vol. 3, p. 234–241. New York: P.B. Hoeber 1959.Google Scholar
  54. Lindsley, D.L., T.T. Odell jr., and F.G. Tausche: Implantation of functional erythropoietic elements following total-body irradiation. Proc. Soc. exp. Biol. (N.Y.) 90, 512–515 (1955).CrossRefGoogle Scholar
  55. Maisin, H.: Contribution à l’étude du syndrome médullaire après irradiation. Bruxelles: Arscia, S.A.1959.Google Scholar
  56. Maisin, H.: La greffe de moelle osseuse. Rev. Quest. Sci. 524-540 (oct. 1959).Google Scholar
  57. Maisin, H., et M. Mandart: La valeur comparée de quelques techniques radio-et radiumthérapiques dans le traitement des myéloses chroniques. J Radiol. Électrol. 35, 566–568 (1954).Google Scholar
  58. Maisin, J.: L’emploi de peroxydes et de corps désaturés en thérapeutique. C.R. Soc. belge Biol. 126, 89 (1937).Google Scholar
  59. Maisin, J.: Le traitement du cancer du sein par curiethérapie et roentgenthérapie. Acta radiol. (Stockh.) 28, 593–610 (1947).CrossRefGoogle Scholar
  60. Maisin, J.: Essai d’immunoprophylaxie de cancers expérimentalement provoqués. Bull. Acad. roy. Méd. Belg. 4, 197–244 (1964).PubMedGoogle Scholar
  61. Maisin, J., P. Dumont et A. Dunjic: Au sujet de l’influence de l’acide ribonucléique de levure sur la survie au 30è jour de rats irradiés in toto. Nouvelles recherches. C.R. Soc. Biol. (Paris) 154, 429–432 (1960).Google Scholar
  62. Maisin, J., P. Dumont et A. Dunjic: Au sujet de l’influence d’injections d’hydrolysats alcalins d’acide ribonucléique de levure sur la survie au 30è jour de rats irradiés avec une dose de 500 r. C.R. Soc. Biol. (Paris) 154, 475–479 (1960).Google Scholar
  63. Maisin, J., P. Dumont et A. Dunjic: Yeast ribonucleic acid and its nucleotides as recovery factors in rats receiving an acute whole-body dose of X-rays. Nature (Lond.) 186, 487–488 (1960).CrossRefGoogle Scholar
  64. Maisin, J., J. van Lancker, A. Dunjic, G. Lambert et L. Passau: De l’influence de l’état de jeûne sur la survie des animaux irradiés in toto avec foie protégé. C.R. Soc. Biol. (Paris) 147, 1517–1520 (1953).Google Scholar
  65. Maisin, J., J. van Lancker, G. Lambert, L. Passau, M. Mandart, A. Dunjic, and H. Maisin: The role of the liver region in the protection against ionizing radiation. Acta radiol. (Stockh.), Suppl. 116, 40–48 (1954).CrossRefGoogle Scholar
  66. Maisin, J., et G. Langerock: Le traitement du cancer du rectum inopérable. J. belge Radiol. 36, 335–336 (1953).PubMedGoogle Scholar
  67. Maisin, J., et H. Maisin: Le cancer. Monogr. méd. sci. 4, 9–80 (1952).Google Scholar
  68. Maisin, J., et J. Keusters: L’utilisation des supervoltages et des grandes masses de radio-éléments dans le traitement du cancer en général. Acta Un. int. Cancr. 10, 425–447 (1954).PubMedGoogle Scholar
  69. Maisin, J., et J. Keusters: Utilisation des super-voltages et des grandes masses de radio-éléments dans le traitement du cancer en général. J. belge Radiol. 39, 88–126 (1956).PubMedGoogle Scholar
  70. Maisin, J., J. van Lancker et J. Keusters: Le cancer du poumon. J. belge Radiol. 37, 395–430 (1954).Google Scholar
  71. Martin, H.E.: Fractional or divided dose method of external irradiation in treatment of cancer of pharynx, tonsil, larynx and paranasal sinuses. Acta radiol. (Stockh.) 16, 1–24 (1935).CrossRefGoogle Scholar
  72. Mathe, G., J. Bernard, L. Schwarzenberg, M.J. Larrieu, C.M. Lalanne, A. Dutreix, P.F. Denoix, J. Surmont, V. Schwarzmann et B. Ceoara: Essai de traitement de sujets atteints de leucémie aiguë en rémission par l’irradiation totale suivie de transfusion de moelle osseuse homologue. Rev. franç. Étud. clin. Biol. 4, 675–704 (1959).PubMedGoogle Scholar
  73. Mathe, G., J. Bernard, M.J. de Vries, L. Schwarzenberg, M.J. Larrieu, C.M. Lalanne, A. Dutreix, J.L. Amiel et J. Surmont: Nouveaux essais de greffe de moelle osseuse homologue après irradiation totale chez des enfants atteints de leucémie aiguë en rémission. Rev. Hémat. 15, 115–161 (1960).PubMedGoogle Scholar
  74. Maxwell, D.R.: Some experiments with labelled compounds related to 2-methyl-l:4-naphtho-hydroquinone di-phosphate (Synkavit). Radioisotope Conference Oxford. London: Butterworth & Co. 1954.Google Scholar
  75. Minot, G.R., T.E. Buckman, and R. Isaacs: Chronic myelogenous leukemia. J. Amer. med. Ass. 82, 1489–1494 (1924).CrossRefGoogle Scholar
  76. Mitchell, J.B.: Laboratory studies and clinical radiotherapeutic trials of some chemical radiosensitisers. Acta radiol. (Stockh.), Suppl. 116, 431–440 (1953).Google Scholar
  77. Nakahara, W., and F. Fukuoka: Toxohormone, a toxic hormonal factor originating from cancer tissue. Acta Un. int. Cancr. 15, 858–860 (1959).PubMedGoogle Scholar
  78. New, G.B., F.A. Figi, F.Z. Havens, and J.B. Erich: Carcinoma of the larynx. Surg. Gynec. Obst. 85, 623–629 (1947).Google Scholar
  79. Pack, G.T., and I.M. Ariel: Treatment of cancer and allied diseases. New York: P.B. Hoeber 1958.Google Scholar
  80. Pack, G.T., and I.M. Ariel: Treatment of cancer and allied diseases. Tumors of nervous system, vol. 2. New York: P.B. Hoeber 1959.Google Scholar
  81. Patt, H.M., E.B. Tyree, H.L. Straube, and D.E. Smith: Cysteine protection against X-irradiation. Science 110, 213–214 (1949).PubMedCrossRefGoogle Scholar
  82. Price-Thomas, C.: The value of radical and conservative resection in the treatment of carcinoma of the lung. Acta Un. int. Cancr. 15, 453–458 (1959).Google Scholar
  83. Raven, R.W.: Cancer of the pharynx, larynx and oesophagus and its surgical treatment. London: Butterworth & Co. 1958.Google Scholar
  84. Rawson, R.W., and J.B. Trunnell: Radioactive iodine in the study and treatment of carcinoma of the thyroid. Manual of artificial radioisotope therapy. New York: Academic Press 1951.Google Scholar
  85. Reymaeker, A. de, et G. de Dobbeleer: Contribution au progrès de la stéréotaxie cérébrale. Un nouvel encéphalotome humain. Institut de Neurologie, Louvain. Acta neurol. belg. 59, 652–666 (1959).Google Scholar
  86. Riches, E.W., J.H. Griffiths, and A.C. Thackeray: Brit. J. Urol. 23, 297–356 (1951). Quoted by P.B. Kunkler and A.J.H. Rains in Treatment of cancer in clinical practice. Edinburgh and London: J.S. Livingstone 1959.PubMedCrossRefGoogle Scholar
  87. Roswit, B.: Present status of chemotherapy of bronchial cancer. Radiology 69, 499–507 (1957).PubMedGoogle Scholar
  88. Roux-Berger, J., J. Baud et J. Courtial: Cancer de la partie mobile de la langue, le curage ganglionnaire prophylactique est-il justifié? Statistique de la Fondation Curie. Mém. Acad. Chir. 75, 120–126 (1949).Google Scholar
  89. Schinz, H.R., u. J. Wellauer: Das TNM-System bei den wichtigsten Krebslokalisationen und dessen Ausbau. Fortschr. Röntgenstr. 81, 2–31 (1959).Google Scholar
  90. Scott, L.S.: Wilms’ tumour: its treatment and prognosis. Brit. med. J. 1956, 200-203.Google Scholar
  91. Sharp, G.S., W.K. Bullock, and J.W. Hazlet: Oral cancer and tumors of the jaws. New York: McGraw-Hill Book Co., Inc. 1956.Google Scholar
  92. Snell, G.D.: The genetics of transplantation. J. nat. Cancer Inst. 14, 691–700 (1953).PubMedGoogle Scholar
  93. Stouta, P.: Fibrosarcoma. The malignant tumor of fibroblasts. Cancer (Philad.) 1, 30–63 (1948).CrossRefGoogle Scholar
  94. T’Ang Yu-Hans: Les bases expérimentales de la radiothérapie totale et subtotale. Thèse de l’Institut du Cancer de l’Université de Louvain (Directeur: Prof. J. Maisin) 1939. (Imprimerie Médicale et Scientifique, 34, rue Botanique, Bruxelles.)Google Scholar
  95. Taylor, S.G., D.P. Slaughter, W. Smejkal, E.F. Fowler, and F.W. Preston: The effect of sex hormones on advanced carcinoma of the breast. Cancer (Philad.) 1, 603–617 (1948).CrossRefGoogle Scholar
  96. Trentin, J.J.: Mortality and skin transplantability in X-irradiated mice receiving isologous, homologous or heterologous bone marrow. Proc. Soc. exp. Biol. (N.Y.) 92, 688–693 (1956).CrossRefGoogle Scholar
  97. Trentin, J.J.: Induced tolerance and “homologous disease” in X-irradiated mice protected with homologous bone marrow. Proc. Soc. exp. Biol. (N.Y.) 96, 139–144 (1957).CrossRefGoogle Scholar
  98. Union Internationale contre le Cancer: Classification clinique des tumeurs malignes du sein (projet 1956). Commission de Recherches, 25, rue d’Ulm, Paris Vè, 1956.Google Scholar
  99. Wambersie, A., et J. Maisin: Grains d’or en thérapie interstitielle, doses et répartition spatiale. J. belge Radiol. 41, 685–728 (1958).Google Scholar
  100. Wambersie, A., J.M. Brucher et R. Constant: Lésions produites par implantation intracérébrale de grains d’Iridium 194. Applications thérapeutiques. J. belge Radiol. 42, 688–709 (1959).PubMedGoogle Scholar
  101. Whitlock, G.F., J.R. McDonald, and E.N. Cook: Primary carcinoma of the ureter: a pathologic and prognostic study. J. Urol. (Baltimore) 73, 245–253 (1955).Google Scholar
  102. Wood, D.C.: Researches on the radiotherapy of oral cancer. Publication No 267. London: Medical Research Council 1950.Google Scholar
  103. Zilber, L.A.: Studies on tumor antigens. J. nat. Cancer Inst. 18, 341–358 (1957).PubMedGoogle Scholar
  104. Zuppinger, A.: IXth Internat. Congr. of Radiology, München 1959, Bd. I, S. 626–635. Stuttgart: Georg Thieme 1961.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1967

Authors and Affiliations

  • J. Maisin
  • H. Maisin
  • C. Deckers

There are no affiliations available

Personalised recommendations